Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide

British Journal of Pharmacology

Volumn 168, Issue 6, 2013, Pages 1430-1444

  Ambrosino, Paolo ^a   Soldovieri, Maria Virginia ^a   Russo, Claudio ^a   Taglialatela, Maurizio ^a,b  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

bradykinin; capsaicin; intracellular calcium concentrations; pain; palmitoylethanolamide; PPAR transcription factor; transient receptor potential vanilloid type 1 channels

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; BRADYKININ; CALCIUM ION; CAPSAICIN; COMPLEMENTARY DNA; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; VANILLOID RECEPTOR 1;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; HETEROLOGOUS EXPRESSION; MICROFLUOROMETRY; MOLECULAR IMAGING; MOUSE; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PATCH CLAMP; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SENSORY NERVE CELL; SINGLE CELL ANALYSIS; UPREGULATION;

ACTION POTENTIALS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM SIGNALING; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DRUG ANTAGONISM; ENDOCANNABINOIDS; ETHANOLAMINES; MEMBRANE TRANSPORT MODULATORS; MICE; NERVE TISSUE PROTEINS; PALMITIC ACIDS; PPAR ALPHA; RATS; RECOMBINANT PROTEINS; SENSORY RECEPTOR CELLS; TACHYPHYLAXIS; TRPV CATION CHANNELS;

EID: 84874400499     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12029     Document Type: Article

References (69)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. 2+ influx. J Androl 26: 429-436.
3. Appendino G, Ligresti A, Minassi A, Cascio MG, Allarà M, Taglialatela-Scafati O, et al. (2009). Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes. J Med Chem 52: 3001-3009.
4. Boland LM, Dingledine R, (1990). Multiple components of both transient and sustained barium currents in a rat dorsal root ganglion cell line. J Physiol 420: 223-245.
5. Brown PJ, Stuart LW, Hurley KP, Lewis MC, Winegar DA, Wilson JG, et al. (2001). Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis. Bioorg Med Chem Lett 11: 1225-1227.
6. Calignano A, La Rana G, Giuffrida A, Piomelli D, (1998). Control of pain initiation by endogenous cannabinoids. Nature 394: 277-281.
7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D, (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
8. Cheng T, Zhao Y, Li X, Lin F, Xu Y, Zhang X, et al. (2007). Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J Chem Inf Model 47: 2140-2148.
9. Chung MK, Güler AD, Caterina MJ, (2008). TRPV1 shows dynamic ionic selectivity during agonist stimulation. Nat Neurosci 11: 555-564.
10. Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G, (2002). Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 135: 181-187.
11. Daigle TL, Kearn CS, Mackie K, (2008). Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology 54: 36-44.
12. Darmani NA, Izzo AA, Degenhardt B, Valenti M, Scaglione G, Capasso R, et al. (2005). Involvement of the cannabimimetic compound, N-palmitoyl- ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. Neuropharmacology 48: 1154-1163.
13. De Petrocellis L, Davis JB, Di Marzo V, (2001). Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett 506: 253-256.
14. De Petrocellis L, Guida F, Moriello AS, De Chiaro M, Piscitelli F, de, Novellis V, et al. (2011). N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity. Pharmacol Res 63: 294-299.
15. Dedov VN, Roufogalis BD, (2000). Mitochondrial calcium accumulation following activation of vanilloid (VR1) receptors by capsaicin in dorsal root ganglion neurons. Neuroscience 95: 183-188.
16. Di Marzo V, Melck D, De Petrocellis L, Bisogno T, (2000). Cannabimimetic fatty acid derivatives in cancer and inflammation. Prostaglandins Other Lipid Mediat 61: 43-61.
17. Docherty RJ, Yeats JC, Piper AS, (1997). Capsazepine block of voltage-activated calcium channels in adult rat dorsal ganglion neurons in culture. Br J Pharmacol 121: 1461-1467.
18. Doering CJ, Zamponi GW, (2003). Molecular pharmacology of high voltage-activated calcium channels. J Bioenerg Biomembr 35: 491-505.
19. + currents upon activation. Brain Res 590: 329-333.
20. Ferreira J, da Silva GL, Calixto JB, (2004). Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 141: 787-794.
21. Francel PC, Harris K, Smith M, Fishman MC, Dawson G, Miller RJ, (1987). Neurochemical characteristics of a novel dorsal root ganglion X neuroblastoma hybrid cell line, F-11. J Neurochem 48: 1624-1631.
22. Gearing KL, Göttlicher M, Teboul M, Widmark E, Gustafsson JA, (1993). Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci U S A 90: 1440-1444.
23. Goswami C, Rademacher N, Smalla KH, Kalscheuer V, Ropers HH, Gundelfinger ED, et al. (2010). TRPV1 acts as a synaptic protein and regulates vesicle recycling. J Cell Sci 123: 2045-2057.
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
25. Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, et al. (2004). Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology 46: 133-149.
26. Helyes Z, Nemeth J, Than M, Bolcskei K, Pinter E, Szolcsanyi J, (2003). Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. Life Sci 73: 2345-2353.
27. Ho WS, Barrett DA, Randall MD, (2008). 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol 155: 837-846.
28. Jaggar SI, Hasnie FS, Sellaturay S, Rice AS, (1998). The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76: 189-199.
29. Jean-Gilles L, Feng S, Tench CR, Chapman V, Kendall DA, Barrett DA, et al. (2009). Plasma endocannabinoid levels in multiple sclerosis. J Neurol Sci 287: 212-215.
30. Khasabova IA, Xiong Y, Coicou LG, Piomelli D, Seybold V, (2012). Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons. J Neurosci 32: 12735-12743.
31. Koplas PA, Rosenberg RL, Oxford GS, (1997). The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J Neurosci 17: 3525-3537.
32. Lambert DM, DiPaolo FG, Sonveaux P, Kanyonyo M, Govaerts SJ, Hermans E, et al. (1999). Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta 1440: 266-274.
33. Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ, (2002). The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 9: 663-674.
34. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K, (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A 105: 2699-2704.
35. Lázár J, Szabõ T, Kovács L, Blumberg PM, Bírõ T, (2003). Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems. Cell Mol Life Sci 60: 2228-2240.
36. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A, (1996). Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19: 514-520.
37. Liu Q, Bhat M, Bowen WD, Cheng J, (2009). Signaling pathways from CB1 receptor activation to inhibition of NMDA-mediated calcium influx and neurotoxicity in dorsal root ganglion neurons. J Pharmacol Exp Ther 331: 1062-1070.
38. LoVerme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, et al. (2005). The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67: 15-19.
39. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ, (2004). Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328: 991.
40. Mechoulam R, Fride E, Di Marzo V, (1998). Endocannabinoids. Eur J Pharmacol 359: 1-18.
41. Moran MM, McAlexander MA, Bírõ T, Szallasi A, (2011). Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10: 601-620.
42. Movahed P, Jönsson BA, Birnir B, Wingstrand JA, Jørgensen TD, Ermund A, et al. (2005). Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J Biol Chem 280: 38496-38504.
43. 2+ fluxes in rabbit T-tubule membranes. Arch Biochem Biophys 434: 344-351.
44. Papakosta M, Dalle C, Haythornthwaite A, Cao L, Stevens EB, Burgess G, et al. (2011). The chimeric approach reveals that differences in the TRPV1 pore domain determine species-specific sensitivity to block of heat activation. J Biol Chem 286: 39663-396672.
45. Platika D, Boulos MH, Baizer L, Fishman MC, (1985). Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells. Proc Natl Acad Sci U S A 82: 3499-3503.
46. Pliska V, (1999). Partial agonism: mechanisms based on ligand-receptor interactions and on stimulus-response coupling. J Recept Signal Transduct Res 19: 597-629.
47. Raymon HK, Thode S, Zhou J, Friedman GC, Pardinas JR, Barrere C, et al. (1999). Immortalized human dorsal root ganglion cells differentiate into neurons with nociceptive properties. J Neurosci 19: 5420-5428.
48. Ropero AB, Juan-Picõ P, Rafacho A, Fuentes E, Bermúdez-Silva FJ, Roche E, et al. (2009). Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR alpha ligands in mouse pancreatic islets of Langerhans. J Endocrinol 200: 127-138.
49. Ross RA, Coutts AA, McFarlane SM, Anavi-Goffer S, Irving AJ, Pertwee RG, et al. (2001). Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 40: 221-232.
50. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152: 1092-1101.
51. Samways DS, Egan TM, (2011). Calcium-dependent decrease in the single-channel conductance of TRPV1. Pflugers Arch 462: 681-691.
52. Sándor Z, Varga A, Horváth P, Nagy B, Szolcsányi J, (2005). Construction of a stable cell line uniformly expressing the rat TRPV1 receptor. Cell Mol Biol Lett 10: 499-514.
53. Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R, (1997). Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem 40: 659-667.
54. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, et al. (2002). Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci U S A 99: 10150-10155.
55. Showalter VM, Compton DR, Martin BR, Abood ME, (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278: 989-999.
56. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, et al. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129: 227-230.
57. Smart D, Jonsson KO, Vandevoorde S, Lambert DM, Fowler CJ, (2002). 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br J Pharmacol 136: 452-458.
58. 2+ influx via TRPV1 channels. EMBO J 24: 3026-3037.
59. Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, et al. (2001). Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci 21: 1104-1109.
60. Vandevoorde S, Lambert DM, Smart D, Jonsson K-O FCJ, (2003). N-Morpholino- and N-Diethyl-analogues of Palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity. Bioorg Med Chem 11: 817-825.
61. Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA, (2001). Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 534: 813-825.
62. Vetter I, Lewis RJ, (2010). Characterization of endogenous calcium responses in neuronal cell lines. Biochem Pharmacol 79: 908-920.
63. Vyklický L, Nováková-Tousová K, Benedikt J, Samad A, Touska F, Vlachová V, (2008). Calcium-dependent desensitization of vanilloid receptor TRPV1: a mechanism possibly involved in analgesia induced by topical application of capsaicin. Physiol Res 57: S59-S68.
64. Xu H, Blair NT, Clapham DE, (2005). Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci 25: 8924-8937.
65. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, et al. (2002). Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415: 813-817.
66. 2+) influx to synaptosomes from rat brain. Pharmacology 76: 157-162.
67. 2+ currents through capsaicin- and proton-activated ion channels in rat dorsal root ganglion neurones. J Physiol 503: 67-78.
68. Zolese G, Bacchetti T, Ambrosini A, Wozniak M, Bertoli E, Ferretti G, (2005). Increased plasma concentrations of palmitoylethanolamide, an endogenous fatty acid amide, affect oxidative damage of human low-density lipoproteins: an in vitro study. Atherosclerosis 182: 47-55.
69. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, et al. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457.